Nature's Sunshine Products, Inc. (NASDAQ:NATR) Shares Bought by Paradigm Capital Management Inc. NY

Paradigm Capital Management Inc. NY grew its holdings in Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) by 26.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 695,079 shares of the company's stock after buying an additional 146,879 shares during the period. Paradigm Capital Management Inc. NY owned 3.71% of Nature's Sunshine Products worth $10,475,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Jump Financial LLC acquired a new stake in Nature's Sunshine Products in the 4th quarter valued at about $208,000. Trexquant Investment LP purchased a new position in Nature's Sunshine Products during the fourth quarter worth approximately $217,000. Wasatch Advisors LP purchased a new position in Nature's Sunshine Products during the fourth quarter worth approximately $7,430,000. BNP Paribas Financial Markets boosted its stake in Nature's Sunshine Products by 12.7% during the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company's stock worth $316,000 after buying an additional 1,715 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in shares of Nature's Sunshine Products by 8.9% in the 1st quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company's stock worth $523,000 after acquiring an additional 2,054 shares during the last quarter. 79.40% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Canaccord Genuity Group began coverage on shares of Nature's Sunshine Products in a report on Friday, September 13th. They issued a "buy" rating and a $18.00 target price on the stock. StockNews.com upgraded Nature's Sunshine Products from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, September 10th. DA Davidson cut their target price on Nature's Sunshine Products from $23.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, August 12th. Finally, Canaccord Genuity Group initiated coverage on Nature's Sunshine Products in a research note on Friday, September 13th. They issued a "buy" rating and a $18.00 price target on the stock.

Nature's Sunshine Products Stock Performance

Shares of NASDAQ NATR traded down $0.17 during trading on Tuesday, reaching $13.38. The stock had a trading volume of 21,218 shares, compared to its average volume of 56,572. The company has a market cap of $250.61 million, a P/E ratio of 15.94 and a beta of 0.87. Nature's Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $21.72. The business's 50-day moving average price is $14.28 and its 200-day moving average price is $16.17.

Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by ($0.18). The business had revenue of $110.55 million during the quarter. Nature's Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%.

Nature's Sunshine Products Profile

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.